Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics

Nat Biotechnol. 2023 Feb;41(2):212-221. doi: 10.1038/s41587-022-01447-3. Epub 2022 Sep 8.

Abstract

The analysis of cell-free DNA (cfDNA) in plasma provides information on pathological processes in the body. Blood cfDNA is in the form of nucleosomes, which maintain their tissue- and cancer-specific epigenetic state. We developed a single-molecule multiparametric assay to comprehensively profile the epigenetics of plasma-isolated nucleosomes (EPINUC), DNA methylation and cancer-specific protein biomarkers. Our system allows for high-resolution detection of six active and repressive histone modifications and their ratios and combinatorial patterns on millions of individual nucleosomes by single-molecule imaging. In addition, our system provides sensitive and quantitative data on plasma proteins, including detection of non-secreted tumor-specific proteins, such as mutant p53. EPINUC analysis of a cohort of 63 colorectal cancer, 10 pancreatic cancer and 33 healthy plasma samples detected cancer with high accuracy and sensitivity, even at early stages. Finally, combining EPINUC with direct single-molecule DNA sequencing revealed the tissue of origin of colorectal, pancreatic, lung and breast tumors. EPINUC provides multilayered information of potential clinical relevance from limited (<1 ml) liquid biopsy material.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor
  • Cell-Free Nucleic Acids* / metabolism
  • DNA Methylation / genetics
  • Epigenesis, Genetic / genetics
  • Humans
  • Neoplasm Proteins / genetics
  • Neoplasms* / diagnosis
  • Neoplasms* / genetics
  • Nucleosomes* / genetics
  • Nucleosomes* / metabolism
  • Single Molecule Imaging

Substances

  • Biomarkers, Tumor
  • Cell-Free Nucleic Acids
  • Neoplasm Proteins
  • Nucleosomes